TY - ADVS TI - Novel immunotherapeutic proteins: immunoligand AU - Strom, Terry A2 - Waldmann, Herman PY - 2007 DA - 2007/10/01 N1 - Archived at 2019/06/13 UR - https://hstalks.com/bs/596/ AB - Potential advantages of mAB, Challenges for mAB, Antibody based therapeutic proteins, Attributes of immunoligands, Creation of Ig-based fusion proteins, Non-cytolytic IL-2/Fc fusion protein, Vaccine trial design, Creation of cytolytic IL-15R antagonist fusion protein, Application of immunoligand: immunogen for mAB production, to stain the cognate ligand, to identify cell surface cognate ligands via immunoprecipitation, to create long lived proteins to test the function of the targeting ligand in vivo and to modulate immune responses, Challenges for immunoligands DB - The Biomedical & Life Sciences Collection SN - 2056-452X ID - 1288 PB - Henry Stewart Talks ER -